Ameriprise Financial Inc. Reduces Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Ameriprise Financial Inc. cut its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 21.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 264,742 shares of the company's stock after selling 72,243 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.31% of Pediatrix Medical Group worth $3,473,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in MD. Vanguard Group Inc. lifted its position in Pediatrix Medical Group by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 10,812,611 shares of the company's stock worth $141,861,000 after acquiring an additional 113,976 shares during the period. Pacer Advisors Inc. acquired a new stake in Pediatrix Medical Group during the 4th quarter worth approximately $35,492,000. Boston Partners lifted its position in Pediatrix Medical Group by 25.2% during the 4th quarter. Boston Partners now owns 1,956,353 shares of the company's stock worth $25,922,000 after acquiring an additional 393,600 shares during the period. Geode Capital Management LLC lifted its position in Pediatrix Medical Group by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company's stock worth $25,562,000 after acquiring an additional 11,045 shares during the period. Finally, American Century Companies Inc. lifted its position in Pediatrix Medical Group by 628.2% during the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock worth $22,820,000 after acquiring an additional 1,500,485 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Price Performance

MD stock traded down $0.08 during midday trading on Friday, hitting $14.15. 968,608 shares of the stock were exchanged, compared to its average volume of 855,808. The stock's 50-day moving average price is $13.72 and its 200-day moving average price is $14.03. The stock has a market cap of $1.22 billion, a price-to-earnings ratio of -11.79, a PEG ratio of 1.74 and a beta of 1.26. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.08. The firm had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. Pediatrix Medical Group's revenue was down 7.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.20 earnings per share. Research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on MD. Truist Financial decreased their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. UBS Group reduced their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a report on Monday, May 12th. Finally, Macquarie raised their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $16.67.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.